Suggestions

HQY · NASDAQ

HEALTHEQUITY INC

Private beta

Sector unavailable · Industry unavailable

$96.26

+1.81%

Close on Sep 11, 2026

Insufficient Data

Updated 12/20/2023

Long-term research evidence only. No price targets, no trading signals, no recommendations.

Investment Report Card

HEALTHEQUITY INC

Sector unavailable · Data confidence partial

74 / 100

Rank #62 of 1,152 qualified companies

Top 9% · Worth a Closer Look

Risk Intelligence

Core Model
B+

80 / 100

Insufficient Data

How strong and defensively sound is the company?

Above average on this measure.

Long-Term Potential

Research Model
C+

69 / 100

Insufficient Data

Does the business have the characteristics needed to create value over many years?

Around the middle of the covered universe.

Fundamental Momentum

Research Model
C

63 / 100

Insufficient Data

Is the underlying business getting stronger or weaker?

Around the middle of the covered universe.

Ownership Intelligence

Supplemental Intelligence
C

63 / 100

Positive disclosed activity

What are important owners actually doing?

Around the middle of the covered universe.

Valuation Intelligence

Research Model
B−

70 / 100

Attractive

Is today's price reasonable?

Above average on this measure — and valuation is researched separately from the Suggested Investment Score.

Capital Returns Intelligence

Research Model
F

38 / 100

Limited Capital Returns

How effectively does the company reward shareholders?

Weaker than most covered companies on this measure — and capital returns are researched separately from the Suggested Investment Score.

Why it stands out

  • More disclosed holders are new or increasing than reducing or exiting.
  • Attractive valuation: the stock reads 70 out of 100 on Valuation Intelligence (Attractive) relative to its own history and comparable companies.

What holds it back

No weakening evidence is recorded in today's readings.

Long-term view

HEALTHEQUITY INC scores 69 on Long-Term Potential (C+), described by the research model as insufficient data. This describes business characteristics only — it is not a forecast of future returns.

Ownership view

Disclosed ownership evidence reads 63 (C): Positive disclosed activity. 4 tracked managers disclosed a position in the latest reporting period. Ownership filings are historical disclosures, not signals.

Valuation view

HEALTHEQUITY INC reads 70 out of 100 on Valuation Intelligence, recorded as Attractive. The stock currently trades below most of its own recent valuation history and above comparable companies. This describes the price being paid relative to the company's financials — it is not a forecast and not a fair value. Valuation Intelligence is a research model and contributes nothing to the Suggested Investment Score or the daily ranking.

Capital returns view

HEALTHEQUITY INC reads 38 out of 100 on Capital Returns Intelligence (Limited Capital Returns), reflecting no measurable direct capital returns. Direct capital returns are limited because the company continues reinvesting most of its cash. Capital Returns Intelligence is a research model and contributes nothing to the Suggested Investment Score or the daily ranking.

What changed

No meaningful recorded changes in the stored history.

Risk Intelligence is a core model, Long-Term Potential, Fundamental Momentum, Valuation Intelligence and Capital Returns Intelligence are research models, and Ownership Intelligence is supplemental descriptive evidence. Valuation Intelligence and Capital Returns Intelligence each contribute 0% to the Suggested Investment Score. Nothing here is a recommendation.

Compare HQY with other companies

Appears in

Rule-based membership

Membership means the company satisfied a published rule on the latest research build. It is not a recommendation.

About a minute to read

The 60-Second Investment Brief

Written from stored research readings only. No hype. No trading signals. Just better evidence.

Why it's interesting

HEALTHEQUITY INC (HQY) scores 74 out of 100 and ranks #62 of 1,152 qualified companies today. That places it in the top 9% of ranked companies. The stored tier for that score is worth a closer look.

Business strength

Risk Intelligence reads 80 out of 100 (B+), recorded as insufficient data. Above average on this measure.

Long-term opportunity

Long-Term Potential reads 69 out of 100 (C+), recorded as insufficient data. Around the middle of the covered universe.

What's improving or weakening

Fundamental Momentum reads 63 out of 100 (C), recorded as insufficient data. Around the middle of the covered universe.

What important owners are doing

Ownership Intelligence reads 63 out of 100 (C), recorded as positive disclosed activity. Around the middle of the covered universe.

What kind of price you'd be paying

Valuation currently appears favourable: Valuation Intelligence reads 70 out of 100 (B−), recorded as Attractive. HEALTHEQUITY INC reads 70 out of 100 on Valuation Intelligence, recorded as Attractive. The stock currently trades below most of its own recent valuation history and above comparable companies. This describes the price being paid relative to the company's financials — it is not a forecast and not a fair value. Valuation Intelligence is a research model and contributes nothing to the Suggested Investment Score or the daily ranking.

How the company rewards shareholders

Capital Returns Intelligence reads 38 out of 100 (F), recorded as Limited Capital Returns. HEALTHEQUITY INC reads 38 out of 100 on Capital Returns Intelligence (Limited Capital Returns), reflecting no measurable direct capital returns. Direct capital returns are limited because the company continues reinvesting most of its cash. Capital Returns Intelligence is a research model and contributes nothing to the Suggested Investment Score or the daily ranking.

What could go wrong

No weakening factors are recorded in today's stored readings, and data confidence is partial. Absence of a recorded weakness is not evidence of safety.

Bottom line

Its strongest recorded evidence is Risk Intelligence. Separately from the score, valuation reads attractive at today's price.

Composite discovery model

Pro Investor Score

Pro Investor Score™

74 / 100

Worth a Closer Look

A 0–100 composite discovery score combining Risk Intelligence, Long-Term Potential, Fundamental Momentum, and Ownership Intelligence. It helps rank qualified companies for further research and does not predict future returns.

Rank
#62 of 694
Percentile
Top 10%
Ranking updated
September 12, 2026
Rank unchanged. Rank unchanged.
Risk Intelligence
80

30% contribution

Long-Term Potential
69

30% contribution

Fundamental Momentum
63

20% contribution

Ownership Intelligence
63

20% contribution

Ownership Intelligence

63 / 100 · Moderately Positive · 20% of the Pro Investor Score

SUPPLEMENTAL / DESCRIPTIVE INTELLIGENCE

Coverage: Good

Elite Investor Activity
50 · Moderately Positive

50% of Ownership Intelligence · 10% of the total score

Tracked professional-manager activity is moderately positive.

Institutional Activity
96 · Strong

20% of Ownership Intelligence · 4% of the total score

Broad institutional evidence from resolved filings is strong.

Insider Activity
Insufficient Data

15% of Ownership Intelligence · 3% of the total score

No discretionary insider transactions are stored for this company, so this evidence is unavailable rather than neutral.

Strategic Ownership
Insufficient Data

15% of Ownership Intelligence · 3% of the total score

No qualifying major-holder filings are stored, so this evidence is unavailable rather than neutral.

Ownership Intelligence summarizes publicly disclosed activity among professional investment managers, broader institutions, company insiders, and significant strategic owners. It adds context to investment research but is not a validated predictor of future performance. Ownership information is publicly reported with a delay; the latest applicable reporting period is 2026-06-30, publicly disclosed 9/11/2026. Congressional activity is unavailable pending legal review and contributes nothing to this reading.

Why it ranks here

  • Strong risk profile

    Risk Intelligence ranks in the top 7% of qualified companies, with normal_risk price risk.

  • Exceptional long-term potential

    Stored profitability, capital efficiency and reinvestment readings rank near the top of the qualified universe.

What holds it back

  • Ownership evidence is not uniformly supportive

    The combined disclosed ownership evidence ranks below the qualified median.

  • Ownership evidence disagrees

    Different owner groups point in different directions, so the combined reading is best read as mixed rather than uniformly favourable.

COMPOSITE DISCOVERY MODEL — RESEARCH STAGE · Data coverage Excellent. Rankings are recalculated daily using the latest available information. Individual components may update at different frequencies based on when new financial and ownership data becomes available.

Researched separately

Valuation Intelligence 70 · Attractive

RESEARCH MODEL

Valuation Intelligence is currently researched separately and does not affect the Suggested Investment Score or daily ranking.

Researched separately

Capital Returns Intelligence 38 · Limited Capital Returns

RESEARCH MODEL

Capital Returns Intelligence is researched separately and contributes 0% to the Suggested Investment Score, the daily rank or any ranking event.

Score explanation

Why this company scores the way it does

Four research areas carry fixed weights. Each area is compared against every other eligible company, then weighted. The four contributions below add to 73.8 of the stored score (73.8).

  • Risk Intelligence

    30% of the score · contributes 27.9 points

    How strong and defensively sound is the company?

    Stands at the 93 percentile of eligible companies · stored reading 80 · 38% of this company’s total score

    How financially sturdy the company has been when conditions turned against it.

    How this area is measured

    Risk Intelligence reads stored balance-sheet strength, historical downside behaviour and the company's price-risk grouping. A stronger reading describes past resilience; it does not protect against future losses.

    Full methodology
  • Long-Term Potential

    30% of the score · contributes 25.6 points

    Does the business have the characteristics needed to create value over many years?

    Stands at the 85 percentile of eligible companies · stored reading 69 · 35% of this company’s total score

    Whether the business has the durable characteristics long-term owners look for.

    How this area is measured

    Long-Term Potential reads durability characteristics such as profitability consistency, cash generation and reinvestment capability over multiple reported periods.

    Full methodology
  • Fundamental Momentum

    20% of the score · contributes 14.4 points

    Is the underlying business getting stronger or weaker?

    Stands at the 72 percentile of eligible companies · stored reading 63 · 20% of this company’s total score

    Whether the reported business results have been getting stronger or weaker.

    How this area is measured

    Fundamental Momentum compares recent reported fundamentals with the company's own earlier periods, so improvement or deterioration is measured against its history rather than against a forecast.

    Full methodology
  • Ownership Intelligence

    20% of the score · contributes 5.8 points

    What are important owners actually doing?

    Stands at the 29 percentile of eligible companies · stored reading 63 · 8% of this company’s total score

    What large reporting owners have actually been doing with their positions.

    How this area is measured

    Ownership Intelligence reads public ownership filings: how many tracked reporting owners hold the company, and whether they were adding, holding, reducing or exiting in the latest disclosed period.

    Full methodology

What is helping the score

  • Risk Intelligence93 percentile, adding 27.9 points.
  • Long-Term Potential85 percentile, adding 25.6 points.
  • Fundamental Momentum72 percentile, adding 14.4 points.

What deserves attention

  • Ownership Intelligence29 percentile, adding only 5.8 of a possible 20 points.
Outside the score

Additional research — not currently included in the primary Suggested Investment Score.

  • Valuation IntelligenceHEALTHEQUITY INC reads 70 out of 100 on Valuation Intelligence, recorded as Attractive. The stock currently trades below most of its own recent valuation history and above comparable companies. This describes the price being paid relative to the company's financials — it is not a forecast and not a fair value.
  • Capital Returns IntelligenceHEALTHEQUITY INC reads 38 out of 100 on Capital Returns Intelligence (Limited Capital Returns), reflecting no measurable direct capital returns. Direct capital returns are limited because the company continues reinvesting most of its cash.

Pro Investor Intelligence™

Reported by insiders, large shareholders and professional funds. Shown beside our research, never blended into it.

Loading professional-investor activity…

Stored snapshots only

What changed

Research-score history available since September 2026.

Stored research history does not yet cover a full 30 days comparison for this company.

A change is reported as meaningful at 8 score points, 5 rank places, or any change of research classification. Nothing here is a recommendation to buy or sell.

Learn the metrics on this page

Plain-English definitions, with the formula and the limitations of each measure.

Fifth research lens · outside the score

Valuation Intelligence

Valuation Intelligence

Is today's price reasonable?

Valuation Intelligence is currently researched separately and does not affect the Suggested Investment Score or daily ranking.

70/ 100

Attractive

RESEARCH MODEL
Excellent coverage

Compared with its history

96

Very Attractive

Is this company expensive or inexpensive compared with its own history?

Compared with peers

32

Expensive

How expensive is this stock compared with similar companies?

Earnings & cash flow

56

Reasonable

How much financial output does an investor receive relative to the price paid?

Growth-adjusted

97

Very Attractive

Does the company's growth help justify the valuation investors are paying?

HEALTHEQUITY INC reads 70 out of 100 on Valuation Intelligence, recorded as Attractive. The stock currently trades below most of its own recent valuation history and above comparable companies. This describes the price being paid relative to the company's financials — it is not a forecast and not a fair value.

Price data through September 11, 2026 · Financial data through the quarter ended July 31, 2026

Valuation history

Stored readings only. The dashed line is this company's own median for the selected measure.

Only one stored valuation reading exists so far, so there is nothing to chart yet. Valuation history builds forward from activation rather than being reconstructed.

Current P/E 33.7x · own median 87.8x · peer median 32.6x

Valuation is inherently uncertain. A stock that appears inexpensive can continue falling, and a stock that appears expensive can continue rising. Valuation Intelligence provides context about the price investors are paying — it does not predict short-term market movements, and it never produces a fair value, a price target or a buy or sell range. Model VALUATION_INTELLIGENCE_V1.

Sixth research lens · outside the score

Capital Returns Intelligence

Capital Returns Intelligence

How effectively does the company reward shareholders?

Capital Returns Intelligence is researched separately and contributes 0% to the Suggested Investment Score, the daily rank or any ranking event.

38/ 100

Limited Capital Returns

RESEARCH MODEL
Excellent coverage

Dividend Quality

Not Applicable — No Dividend

Dividend reliability

This company currently retains rather than distributes cash through dividends. Capital Returns Intelligence therefore places more emphasis on its other measurable shareholder-return behaviors according to the frozen V1 methodology.

Buyback Effectiveness

42

Moderate Capital Returns

Do buybacks actually reduce shares?

The company spends on share repurchases, but much of that activity offsets share issuance rather than materially reducing the share count.

Dilution Control

30

Limited Capital Returns

Is your ownership share protected?

Capital Return Sustainability

48

Moderate Capital Returns

Can the cash flow support it?

Shareholder Yield

25

Limited Capital Returns

Cash returned versus company value

HEALTHEQUITY INC reads 38 out of 100 on Capital Returns Intelligence (Limited Capital Returns), reflecting no measurable direct capital returns. Direct capital returns are limited because the company continues reinvesting most of its cash.

This company currently retains rather than distributes cash through dividends. Capital Returns Intelligence therefore places more emphasis on its other measurable shareholder-return behaviors according to the frozen V1 methodology.

This company spent cash repurchasing stock, but the share count did not fall meaningfully because it also issued shares. Repurchase spending alone did not increase existing shareholders' ownership.

How returned cash was used

Dividends $0.00 · net repurchases $402.87M · total returned $402.87M · 92% of free cash flow

Price data through September 11, 2026 · Financial data through the quarter ended July 31, 2026

Capital returns history

Stored readings only. History builds forward from activation rather than being reconstructed.

Only one stored reading exists for this measure so far, so there is nothing to chart yet.

Why higher yield isn't always better

A very high dividend yield may reflect a falling share price or an unsustainable payout. Capital Returns Intelligence emphasizes consistency and sustainability rather than simply rewarding the highest yield.

Why buybacks can be misleading

Announced or gross buyback spending does not always mean shareholders are gaining ownership. Companies can simultaneously issue shares through employee compensation or acquisitions. Suggested Investments therefore considers actual share-count changes alongside repurchase spending.

What these terms mean
Dividend Yield
The annual dividend relative to the current share price.
Payout Ratio
The share of company earnings used to pay dividends.
Free Cash Flow Payout
How much of the company's available cash is being used for dividends.
Share Repurchases
When a company buys back its own stock.
Dilution
When the number of shares increases, reducing each existing share's percentage ownership of the company.
Shareholder Yield
A combined view of dividends and net share repurchases relative to the company's market value.

Capital Returns Intelligence describes how a company returns capital to shareholders. It is not a measure of stock-price performance, it does not predict future returns, and a strong reading is never a recommendation to buy. Dividends and repurchases can be reduced or stopped at any time. Model CAPITAL_RETURNS_INTELLIGENCE_V1, contributing 0% to the Pro Investor Score.

Stored daily snapshots only

Ranking history

Stored Suggested Investment ranking history
Today#62Score 74
30 days agoNot rankedNo stored score
90 days agoNot rankedNo stored score
First suggestedSeptember 12, 2026
Highest rank#62

In the company’s own words

What this company does

We are a leader and an innovator in providing technology-enabled services that empower consumers to make healthcare saving, spending, and investing decisions. We use our innovative technology to manage consumers' tax-advantaged health savings accounts ("HSAs") and other consumer-directed benefits ("CDBs") offered by employers, including flexible spending accounts and health reimbursement arrangements ("FSAs" and "HRAs"), and to administer Consolidated Omnibus Budget Reconciliation Act ("COBRA"), commuter and other benefits. As part of our services, we provide consumers with payment processing services, personalized benefit information, access to healthcare solutions through our marketplace, and investment advice to grow their tax-advantaged healthcare savings. We believe the shift to greater consumer responsibility for healthcare costs will require a significant portion of consumers under the age of 65 with private health insurance in the United States to use offerings such as ours.

The core of our offerings is the HSA, a financial account through which consumers save, spend, and invest their healthcare dollars on a tax-advantaged basis. As of January 31, 2026, we administered 10.6 million HSAs, with balances totaling $36.5 billion, which we call HSA Assets, as well as 7.2 million complementary CDBs. We refer to the aggregate number of HSAs and other CDBs that we administer as Total Accounts, of which we had 17.8 million as of January 31, 2026.

We reach consumers primarily through relationships with their employers, which we call Clients. We reach Clients primarily through relationships with benefits brokers and advisors, integrated partnerships with a network of health plans, benefits administrators, and retirement plan recordkeepers, which we call Network Partners, and a sales force that calls on Clients directly. As of January 31, 2026, our platforms were integrated with more than 200 Network Partners.

We have increased our share of the growing HSA market from 4% in December 2010 to 20% as of June 2025, measured by HSA Assets. According to the 2025 Midyear Devenir HSA Research Report, as of June 2025, we were the largest HSA provider by number of accounts and the second largest HSA provider by HSA Assets. In addition, we believe we are the largest provider of other CDBs. We seek to differentiate ourselves through our service-driven culture, product breadth, ecosystem connectivity, and proprietary technology, which enables our members to better save, spend, and invest their healthcare dollars. Our proprietary technology allows us to help consumers optimize the value of their HSAs and other CDBs and gain confidence and skills in managing their healthcare costs as part of their financial security.

Quoted from the business section of this company’s 10-K filed March 17, 2026. Read the filing

Four distinct intelligence areas

The IA view

Risk Intelligence

Production core

81

Fundamentally Qualified

No prior period to compare

Business Quality qualification score from the locked IA Defensive Research Core. Price Risk stays a separate category and is never blended in.

As of Sep 11, 2026

Long-Term Potential

Research model

69

Elite Compounder

No prior period to compare

Durable business economics and reinvestment characteristics. Independent external validation is pending.

As of Sep 11, 2026

Fundamental Momentum

Research model

63

Accelerating

No prior period to compare

Direction and breadth of change in underlying business fundamentals. Not a price-momentum signal.

As of Sep 11, 2026

Elite Investor Activity

Supplemental

50

Mid range

No prior period to compare

Only 4 tracked managers disclosed a position — treat as limited coverage.

As of Sep 11, 2026

Intelligence history

Not enough stored history to chart HQY yet. A company needs at least two published research or ownership periods before a trend can be shown.

Share price

HQY price history

Closing prices adjusted for splits and dividends. Past prices do not indicate future results.

6M change
+25.4%
1Y change
+4.2%
3Y change
+37.2%
5Y change
+55.7%
Max change
+33.2%

Last stored close $96.26 · +4.2% over the selected range · 52 sessions shown

Balanced evidence

Why IA likes it

  • More disclosed holders are new or increasing than reducing or exiting.

Risk and uncertainty

What IA doesn’t like

  • No specific negative evidence is available. This is not evidence of low risk.

What would change our view

  • Business Quality falling below the frozen qualification threshold.
  • Price Risk moving to a less favorable category.
  • A sustained reversal in the Fundamental Momentum research evidence.
  • New material public ownership disclosures.

Public filings · descriptive only

Elite Investor Activity

Reporting holders

3

New holders

1

Increasing

1

Reducing

1

Exiting

0

Coverage

Excellent

Positive disclosed activity · Report period 2021-06-30 · Public 12/20/2023

ManagerChangePortfolio weightRankDisclosed

Insufficient high-confidence manager coverage.

Objective stored changes

What changed

No qualifying changes are recorded for this company in the stored research and filing history.

Ownership timeline

No high-confidence public ownership events are available.

General research only. Not personalized advice. Public filings may be delayed, amended, incomplete, or reflect positions that have changed since the reporting date.